New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery

i.guim.co.uk/img/media/58dccb84b5280f4698e629bef42

Targeted Cancer Therapy Shows Promise Combined With Cholesterol-Lowering Drug

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy

Lung Cancer Clinical Trials: Purpose, Phases, and Risks

Cancer and its treatment could impact survivors' ability to work, says national report

Call for action: Ensuring cancer treatment in times of COVID-19 •

Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Brainlab

Cancer patients 'at risk' due to treatment delays, doctors say

Hot chemo' offers new treatment option

Study: Vitamin D may reduce cancer treatment risk

Clinical update, Cancer Nursing Practice